Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Cortical Mastoidectomy with tympanoplasty and Tympanoplasty: Patients with CSOM Mucosal type are treated with surgical management cortical mastoidectomy with tympanoplasty and tympanopl
Sponsors
Jeslin Mole Jose
Eligibility
Inclusion criteria
Inclusion criteria: Patients aged 15 to 60 years Diagnosed with CSOM (tubotympanic type) Dry ear for at least 2 weeks before surgery Complying to regular follow up Willing to provide informed consent and follow up
Exclusion criteria
Exclusion criteria: Presence of cholesteatoma or atticoantral disease Revision tympanoplasty cases No previous mastoid surgery Patients not consenting for the study Patients with sensorineural hearing loss or mixed hearing loss Immunocompromised patients or those with uncontrolled comorbidities Unfit for general anesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Graft Uptake Rate: Defined as successful closure of the tympanic membrane perforation at 3 months postoperatively, confirmed via otoscopic or microscopic examination. Timepoint: Graft Uptake Rate: Defined as successful closure of the tympanic membrane perforation at 3 months postoperatively, confirmed via otoscopic or microscopic examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hearing Improvement: Measured using Pure Tone Audiometry. Air-Bone Gap was calculated at frequencies of 500 Hz, 1000 Hz, and 2000 Hz. Preoperative and postoperative at 6 12 weeks ABG values were compared. Significant hearing improvement was defined as a less than or equal to 10 dB reduction in ABG Timepoint: During the post operative follow up for Hearing Improvement and graft uptake | — |
Countries
India
Contacts
Public ContactShivakumar S
Vinayaka Mission Kirupananda Variyar Medical college and hospitals
Outcome results
None listed